Main Article Content

Abstract

The present study was conducted to assess the efficacy of metformin and voglibose combined with insulin in patients with type II diabetes mellitus. It is a retrospective study was conducted in tertiary care hospitals of Salem district Tamil Nadu with 120 patients who are taking either metformin and insulin or voglibose and insulin according to the inclusion and exclusion criteria. The total number of patients were divided into two groups each consist of 60. Group A was the patients prescribed with metformin and insulin and group B was the patients prescribed with voglibose and insulin. The average efficacy of metformin and voglibose combined with insulin for 10 days, 20 days, 30 days & 40 days were compared using FBS, PPBS, RBS and HbA1C values. The result shows that patients treated with metformin and insulin, the average efficacy of FBS levels on 10, 20, 30 and 40 days were 22.96%, 27.46%, 30.49% and 36.78% respectively. Whereas in the case of voglibose and insulin the efficacy was 23.48%, 28.38%, 32.57%, 40.47% for 10, 20, 30 and 40 days respectively.In the same way, the PPBS, RBS and HbA1C levels were also calculated. While comparing both the groups of patients, the average efficacy of treatment with voglibose and insulin was more effective than metformin and insulin in the tertiary care hospital of Salem district.

Keywords

Metformin Voglibose Insulin Type 2 Diabetes Mellitus

Article Details

How to Cite
Kothai Ramalingam, Veenah Ganesan, Sooraj Sasi, Surya Shanmugam, & Arul Balasubramanian. (2019). Comparative assessment of the efficacy of voglibose and metformin combined with insulin in patients with type 2 diabetes mellitus. International Journal of Research in Pharmaceutical Sciences, 10(3), 2255-2258. https://doi.org/10.26452/ijrps.v10i3.1462